Last reviewed · How we verify
NCT04809870
Esophagectomy in Patients With Liver Cirrhosis
trial testing surgery in Esophageal Cancer in 170 participants. Completed in 10 April 2021.
18 March 2021
Quick facts
| Lead sponsor | Universitätsklinikum Hamburg-Eppendorf |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 170 |
| Start date | 1 October 2020 |
| Primary completion | 18 March 2021 |
| Estimated completion | 10 April 2021 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- surgery
Conditions studied
- Esophageal Cancer — all drugs for Esophageal Cancer →
- Liver Cirrhosis — all drugs for Liver Cirrhosis →
Sponsor
Universitätsklinikum Hamburg-Eppendorf — full company profile →
Who can join
Adults 18 to 100, any sex, with Esophageal Cancer or Liver Cirrhosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Retrospective and confounder adjusted comparison of perioperative and longterm outcomes of patients requiring an esophagectomy for esophageal cancer with and without concomitant liver cirrhosis.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Risk stratification of cirrhotic patients undergoing esophagectomy for esophageal cancer: A single-centre experience.
Grass JK, Küsters N, Kemper M, Tintrup J, et al · · 2022 · cited 3× · PMID 35263385 · DOI 10.1371/journal.pone.0265093
Verify or expand the search:
- PubMed search for NCT04809870
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of surgery
Trials testing the same drug.
- NCT07135336 — Incidence of Postoperative Cognitive Decline in Patients With Preexisting Cognitive Impairment · recruiting
- NCT06912711 — TN Induction and Adjuvant Therapy for Resectable Local Recurrent Nasopharyngeal Carcinoma · Phase 2 · recruiting
- NCT06944470 — JS207 Combined With Chemotherapy in Subjects With Stage II-III NSCLC · Phase 2 · not yet recruiting
- NCT06915909 — Robotic Prostatectomy Artificial Intelligence Low Pressure Pain (RALP) Trial · NA · not yet recruiting
- NCT06751394 — Preoperative Chemoradiotherapy and Toripalimab in Locally Recurrent Rectal Cancer · Phase 2 · not yet recruiting
Other recruiting trials for Esophageal Cancer
Currently open trials in the same condition.
- NCT07464470 — Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Gastroesophageal Cancers · recruiting
- NCT07431281 — Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Meta · Phase 3 · recruiting
- NCT07448493 — Local Treatment Strategies for Brain Metastases of Gastric and Esophageal Cancer · active not recruiting
- NCT07410676 — EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors · Phase 1, PHASE2 · recruiting
- NCT07307560 — High-Flow Nasal Cannula for Preventing Hypoxia During Sedated Endoscopy in High-Risk Obstructive Sleep Apnea Patients · NA · recruiting
Other Universitätsklinikum Hamburg-Eppendorf trials
Trials by the same sponsor.
- NCT07443384 — Complications Associated With Radiofrequency Microneedling in Dermatology: a Delphi Consensus · not yet recruiting
- NCT07385092 — Continuous Vital Sign Monitoring Versus Routine Spot-checks in Patients After Non-cardiac Surgery · NA · recruiting
- NCT07009522 — Hamburg Emotion Awareness and Regulation Group Training for Autistic Adolescents (HEART) · EARLY_PHASE1 · not yet recruiting
- NCT07115394 — EEG Measurements to Capture DBS-induced Electric Potentials · recruiting
- NCT06955884 — Patient Experience of Transoral Versus Transnasal Awake Tracheal Intubation · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04809870 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universitätsklinikum Hamburg-Eppendorf
- Last refreshed: 23 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04809870.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing